GlassScriptPrepare for your visit
Howard S Schub
Neurology with Special Qualifications in Child Neurology · Atlanta, GA · NPI 1386719185
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,497.06
in general payments reported to CMS, 2019-2025 · $38.86 in 2025
The $38.86 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Who reported paying
General payments only, top 6 by amount.
- Ironshore Pharmaceuticals INC. $2,394.33
- Supernus Pharmaceuticals, INC. $1,932.76
- Greenwich Biosciences, INC. $781.24
- Ucb, INC. $360.09
- Eisai INC. $320.60
- Sunovion Pharmaceuticals INC. $318.08
Drugs and devices associated with these payments
Qelbree Azstarys
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Howard Schub listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/289318/howard-s-schub